Search results
Results From The WOW.Com Content Network
List of Antiviral Drugs Antiviral Use Manufacturer Component Type Year approved Abacavir: HIV: ViiV Healthcare: Nucleoside analogue reverse transcriptase inhibitor (NRTI) 1998 Acyclovir (Aciclovir) Herpes Simplex, chickenpox, [2] varicella zoster virus: GSK: guanosine analogue RTI 1981 Adefovir: Hepatitis B [3] Gilead Sciences RTI 2002 , 2003 ...
In March 2022, the BBC wrote, "There are now many drugs that target the virus or our body in different ways: anti-inflammatory drugs that stop our immune system overreacting with deadly consequences, anti-viral drugs that make it harder for the coronavirus to replicate inside the body and antibody therapies that mimic our own immune system to ...
The authors came to the conclusion that no further trials of hydroxychloroquine or chloroquine for treatment of COVID-19 should be carried out. [58] On 26 April 2021, in its amended clinical management protocol for COVID-19, the Indian Ministry of Health lists hydroxychloroquine for use in patients during the early course of the disease. [23]
The Mayo Clinic released a study in June that reported that four people out of a group of 483 individuals who took Paxlovid developed COVID-19 rebound symptoms. It’s not clear why some people ...
Ivermectin, a medication used to treat parasitic infections, was suggested as a possible COVID-19 treatment in an online preprint which utilized a flawed statistical methodology. [159] Importantly, the concentration of the drug that was required to achieve the antiviral effects observed in cell culture was several times higher than what can be ...
Xenon-129 is currently being used as a visualization agent in MRI scans. When a patient inhales hyperpolarized xenon-129 ventilation and gas exchange in the lungs can be imaged and quantified. Unlike xenon-133, xenon-129 is non-ionizing and is safe to be inhaled with no adverse effects. [182]
In unvaccinated high-risk people with COVID‑19, nirmatrelvir/ritonavir can reduce the risk of hospitalization or death by 88% if taken within five days of symptom onset. [20] People who take nirmatrelvir/ritonavir also test negative for COVID‑19 about two and a half days earlier than people who do not. [21]
The first list was published in 1977 and included 208 medications. [8] [2] [9] The WHO updates the list every two years. [10] There are 306 medications in the 14th list in 2005, [11] 410 in the 19th list in 2015, [10] 433 in the 20th list in 2017, [12] [13] 460 in the 21st list in 2019, [14] [15] [16] and 479 in the 22nd list in 2021.